HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Adenocarcinoma

Adenocarcinoma is a type of cancer that originates in the glandular cells lining various organs of the body. These cells typically produce and release fluids such as mucus. Adenocarcinomas can occur in different organs, including the lung, breast, pancreas, colon, and prostate, among others.
Characterized by uncontrolled growth and division of abnormal cells, adenocarcinomas often form tumors and have the potential to spread to other parts of the body if not detected and treated early.
The symptoms of adenocarcinoma can vary depending on the organ affected, making early diagnosis crucial for effective management. Diagnostic methods may include imaging studies, biopsies, and other laboratory tests.
Treatment options for adenocarcinoma commonly involve a multidisciplinary approach, including surgery, chemotherapy, radiation therapy, and targeted therapies. The choice of treatment depends on factors such as the stage of cancer, its location, and the overall health of the patient.
As with many types of cancer, prevention and early detection play key roles in improving outcomes. Regular screenings, lifestyle modifications, and understanding one's risk factors can contribute to the prevention or early identification of adenocarcinoma.
It's important for individuals to be aware of their health, seek medical advice for persistent symptoms, and participate in routine screenings as recommended by healthcare professionals. Ongoing research and advancements in medical science continue to enhance our understanding of adenocarcinoma, leading to more effective treatments and improved patient outcomes.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp